Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

1.

Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma.

Gao Y, Katki H, Graubard B, Pollak M, Martin M, Tao Y, Schoen RE, Church T, Hayes RB, Greene MH, Berndt SI.

Int J Cancer. 2012 Jul 15;131(2):E105-13. doi: 10.1002/ijc.26438. Epub 2011 Nov 2.

PMID:
21932422
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Serum concentrations of insulin-like growth factor and insulin-like growth factor binding protein 3 and recurrent colorectal adenomas.

Flood A, Mai V, Pfeiffer R, Kahle L, Rosen CJ, Lanza E, Schatzkin A.

Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1493-8. doi: 10.1158/1055-9965.EPI-08-0048.

PMID:
18559566
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3.

Fowke JH, Matthews CE, Yu H, Cai Q, Cohen S, Buchowski MS, Zheng W, Blot WJ.

Endocr Relat Cancer. 2010 Jan 29;17(1):51-60. doi: 10.1677/ERC-09-0023. Print 2010 Mar.

PMID:
19786462
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.

Biong M, Gram IT, Brill I, Johansen F, Solvang HK, Alnaes GI, Fagerheim T, Bremnes Y, Chanock SJ, Burdett L, Yeager M, Ursin G, Kristensen VN.

BMC Med Genomics. 2010 Mar 19;3:9. doi: 10.1186/1755-8794-3-9.

PMID:
20302654
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.

Schoen RE, Weissfeld JL, Kuller LH, Thaete FL, Evans RW, Hayes RB, Rosen CJ.

Gastroenterology. 2005 Aug;129(2):464-75.

PMID:
16083703
[PubMed - indexed for MEDLINE]
6.

Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.

Douglas JB, Silverman DT, Pollak MN, Tao Y, Soliman AS, Stolzenberg-Solomon RZ.

Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2298-306. doi: 10.1158/1055-9965.EPI-10-0400. Epub 2010 Aug 10.

PMID:
20699371
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.

Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE, Riboli E.

J Natl Cancer Inst. 2000 Oct 4;92(19):1592-600.

PMID:
11018095
[PubMed - indexed for MEDLINE]
Free Article
8.

Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.

Terry KL, Tworoger SS, Gates MA, Cramer DW, Hankinson SE.

Carcinogenesis. 2009 Dec;30(12):2042-6. doi: 10.1093/carcin/bgp257. Epub .

PMID:
19858071
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies.

Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, Reeves GK, Roddam AW.

Lancet Oncol. 2010 Jun;11(6):530-42. doi: 10.1016/S1470-2045(10)70095-4. Epub 2010 May 14.

PMID:
20472501
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Gender difference in the association of insulin and the insulin-like growth factor axis with colorectal neoplasia.

Yamaji T, Iwasaki M, Sasazuki S, Tsugane S.

Int J Obes (Lond). 2012 Mar;36(3):440-7. doi: 10.1038/ijo.2011.114. Epub 2011 Jun 14.

PMID:
21673650
[PubMed - indexed for MEDLINE]
11.

Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.

Spitz MR, Barnett MJ, Goodman GE, Thornquist MD, Wu X, Pollak M.

Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1413-8.

PMID:
12433720
[PubMed - indexed for MEDLINE]
Free Article
12.

A prospective study of plasma C-peptide and colorectal cancer risk in men.

Ma J, Giovannucci E, Pollak M, Leavitt A, Tao Y, Gaziano JM, Stampfer MJ.

J Natl Cancer Inst. 2004 Apr 7;96(7):546-53.

PMID:
15069117
[PubMed - indexed for MEDLINE]
Free Article
13.

Plasma insulin-like growth factor I is inversely associated with colorectal adenoma recurrence: a novel hypothesis.

Jacobs ET, Martínez ME, Alberts DS, Ashbeck EL, Gapstur SM, Lance P, Thompson PA.

Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):300-5. doi: 10.1158/1055-9965.EPI-07-0764. Epub 2008 Feb 4.

PMID:
18250342
[PubMed - indexed for MEDLINE]
Free Article
14.

Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival.

Cao Y, Lindström S, Schumacher F, Stevens VL, Albanes D, Berndt S, Boeing H, Bueno-de-Mesquita HB, Canzian F, Chamosa S, Chanock SJ, Diver WR, Gapstur SM, Gaziano JM, Giovannucci EL, Haiman CA, Henderson B, Johansson M, Le Marchand L, Palli D, Rosner B, Siddiq A, Stampfer M, Stram DO, Tamimi R, Travis RC, Trichopoulos D, Willett WC, Yeager M, Kraft P, Hsing AW, Pollak M, Lin X, Ma J.

J Natl Cancer Inst. 2014 Jun;106(6):dju085. Erratum in: J Natl Cancer Inst. 2014 Jun;106(6):dju194.

PMID:
24824313
[PubMed - indexed for MEDLINE]
15.

Insulin-like growth factor (IGF)-I, IGF-binding protein-3 and colorectal adenomas in Japanese men.

Teramukai S, Rohan T, Lee KY, Eguchi H, Oda T, Kono S.

Jpn J Cancer Res. 2002 Nov;93(11):1187-94.

PMID:
12460458
[PubMed - indexed for MEDLINE]
16.

Association of a common polymorphism in the human GH1 gene with colorectal neoplasia.

Le Marchand L, Donlon T, Seifried A, Kaaks R, Rinaldi S, Wilkens LR.

J Natl Cancer Inst. 2002 Mar 20;94(6):454-60.

PMID:
11904318
[PubMed - indexed for MEDLINE]
Free Article
17.

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ.

J Natl Cancer Inst. 1999 Apr 7;91(7):620-5.

PMID:
10203281
[PubMed - indexed for MEDLINE]
Free Article
18.

Insulin-like growth factors and prostate cancer: a population-based case-control study in China.

Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, Sesterhenn IA, Mostofi FK, Fears TR, Madigan MP, Ziegler RG, Fraumeni JF Jr, Hsing AW.

Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):421-7.

PMID:
11352850
[PubMed - indexed for MEDLINE]
Free Article
19.

Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study.

Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S; Japan Public Health Center-based Prospective Study Group.

Int J Cancer. 2007 May 1;120(9):2007-12.

PMID:
17266031
[PubMed - indexed for MEDLINE]
20.

Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.

Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X.

J Natl Cancer Inst. 1999 Jan 20;91(2):151-6.

PMID:
9923856
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk